14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.72 $7.24 Wednesday, 24th Apr 2024 AFMD stock ended at $4.88. This is 8.79% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 11.72% from a day low at $4.87 to a day high of $5.44.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jul 13, 2021 $69.40 $69.58 $67.20 $68.60 110 441
Jul 12, 2021 $73.00 $73.30 $69.70 $70.00 63 850
Jul 09, 2021 $72.00 $73.90 $70.45 $72.80 63 082
Jul 08, 2021 $70.90 $72.60 $70.10 $71.20 111 866
Jul 07, 2021 $70.10 $73.00 $69.10 $71.90 138 903
Jul 06, 2021 $72.50 $73.50 $70.70 $70.70 111 708
Jul 02, 2021 $74.10 $76.50 $72.30 $72.80 201 578
Jul 01, 2021 $77.60 $79.90 $73.80 $75.10 859 141
Jun 30, 2021 $82.50 $86.40 $82.20 $85.00 132 360
Jun 29, 2021 $84.50 $85.50 $82.50 $82.90 64 217
Jun 28, 2021 $82.80 $85.00 $82.80 $84.50 72 545
Jun 25, 2021 $83.50 $86.85 $81.80 $82.40 215 657
Jun 24, 2021 $87.60 $87.69 $82.40 $83.10 107 177
Jun 23, 2021 $82.50 $88.10 $82.15 $86.60 114 115
Jun 22, 2021 $80.30 $82.65 $79.80 $82.40 99 864
Jun 21, 2021 $79.90 $82.00 $79.70 $80.00 128 719
Jun 18, 2021 $80.10 $82.10 $78.80 $80.40 119 467
Jun 17, 2021 $80.40 $81.40 $79.90 $80.60 62 505
Jun 16, 2021 $81.40 $81.70 $79.40 $81.60 83 261
Jun 15, 2021 $83.03 $83.60 $80.95 $81.50 75 779
Jun 14, 2021 $81.30 $84.00 $81.00 $83.60 99 992
Jun 11, 2021 $82.00 $83.40 $80.30 $81.50 54 764
Jun 10, 2021 $82.80 $83.50 $81.70 $82.00 61 115
Jun 09, 2021 $83.10 $86.60 $82.60 $83.20 90 526
Jun 08, 2021 $87.10 $87.10 $81.00 $82.70 107 234
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT